RESprotect Overview
- Year Founded
-
2000
- Status
-
Out of Business
- Employees
-
5
- Latest Deal Type
-
Out of Business
RESprotect General Information
Description
Developer of cancer drugs intended for the prevention and treatment of chemotherapeutic drug resistance and radiation therapy resistance. The company's small molecule drugs contain products such as Hsp27 and RP101 which are given orally to cancer patients in combination with standard-of-care chemotherapy, enabling pancreatic cancer patients to kill tumor cells.
Contact Information
Website
www.resprotect.deCorporate Office
- Fiedlerstr. 34
- 01259 Dresden
- Germany
Corporate Office
- Fiedlerstr. 34
- 01259 Dresden
- Germany
RESprotect Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Aug-2023 | Completed | Out of Business | |||
| 3. Secondary Transaction - Private | 01-Sep-2021 | Completed | Generating Revenue | |||
| 2. Secondary Transaction - Private | 15-Apr-2009 | $1M | $6.33M | Completed | Startup | |
| 1. Early Stage VC | 30-Aug-2000 | $6.33M | $6.33M | Completed | Startup |
RESprotect Patents
RESprotect Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-102008035299-A1 | Conjugate, particularly bromovinyl-deoxyuridine for manufacture medicament for inhibiting or suppressing metastasis including distant metastases in cytostatic treatment, includes heat shock protein and nucleoside | Inactive | 29-Jul-2008 | ||
| DE-102008030091-A1 | Uracil derivatives and their use | Active | 25-Jun-2008 | ||
| DE-102008030091-B4 | Uracil derivatives and their use | Inactive | 25-Jun-2008 | ||
| EP-2303848-A2 | Uracil derivatives and use thereof | Inactive | 25-Jun-2008 | ||
| US-20110166096-A1 | Uracil derivatives and use thereof | Active | 25-Jun-2008 | C07D239/54 |
RESprotect Signals
RESprotect FAQs
-
When was RESprotect founded?
RESprotect was founded in 2000.
-
Where is RESprotect headquartered?
RESprotect is headquartered in Dresden, Germany.
-
What is the size of RESprotect?
RESprotect has 5 total employees.
-
What industry is RESprotect in?
RESprotect’s primary industry is Drug Discovery.
-
Is RESprotect a private or public company?
RESprotect is a Private company.
-
What is RESprotect’s current revenue?
The current revenue for RESprotect is .
-
How much funding has RESprotect raised over time?
RESprotect has raised $6.33M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process